Cancer incidence and mortality in patients diagnosed with heart failure: results from an updated systematic review and meta-analysis

[1]  G. Boriani,et al.  2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). , 2022, European heart journal. Cardiovascular Imaging.

[2]  G. Boriani,et al.  2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). , 2022, European heart journal.

[3]  R. Latini,et al.  Cancer Incidence and Mortality According to Pre-Existing Heart Failure in a Community-Based Cohort , 2022, JACC. CardioOncology.

[4]  T. Luedde,et al.  Heart failure is associated with an increased incidence of cancer diagnoses , 2021, ESC heart failure.

[5]  G. Anderson,et al.  The association between heart failure and incident cancer in women: an analysis of the Women's Health Initiative , 2020, European journal of heart failure.

[6]  OUP accepted manuscript , 2021, European Heart Journal.

[7]  P. Ponikowski,et al.  Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) , 2020, European journal of heart failure.

[8]  M. Sormani,et al.  Cancer Mortality in Trials of Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta‐Analysis , 2020, Journal of the American Heart Association.

[9]  Yong-Jin Kim,et al.  Differential risk of incident cancer in patients with heart failure: A nationwide population-based cohort study. , 2020, Journal of cardiology.

[10]  M. Giacca,et al.  Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs. Novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart. , 2020, Cardiovascular research.

[11]  L. Køber,et al.  Prevalence and incidence of various Cancer subtypes in patients with heart failure vs matched controls. , 2020, International journal of cardiology.

[12]  R. D. de Boer,et al.  Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease , 2020, Journal of the American Heart Association.

[13]  Yanwei Xing,et al.  Does heart failure increase the risk of incident cancer? A meta-analysis and systematic review , 2019, Heart Failure Reviews.

[14]  R. D. de Boer,et al.  Cancer and heart disease: associations and relations , 2019, European journal of heart failure.

[15]  Lyanne M. Kieneker,et al.  Heart Failure Stimulates Tumor Growth by Circulating Factors , 2018, Circulation.

[16]  Deepak L. Bhatt,et al.  Lack of Association Between Heart Failure and Incident Cancer. , 2018, Journal of the American College of Cardiology.

[17]  A. Blaes,et al.  Shared Risk Factors in Cardiovascular Disease and Cancer , 2016, Circulation.

[18]  L. Køber,et al.  Incidence of cancer in patients with chronic heart failure: a long‐term follow‐up study , 2016, European journal of heart failure.

[19]  J. Cerhan,et al.  Heart Failure After Myocardial Infarction Is Associated With Increased Risk of Cancer. , 2014, Journal of the American College of Cardiology.

[20]  A. Deswal,et al.  Incident cancer in patients with heart failure: causation or mere association? , 2013, Journal of the American College of Cardiology.

[21]  Timothy J Nelson,et al.  Patients with heart failure have an increased risk of incident cancer. , 2013, Journal of the American College of Cardiology.

[22]  Peter Libby,et al.  Inflammation and cardiovascular disease mechanisms. , 2006, The American journal of clinical nutrition.

[23]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..